NCT03055390View on ClinicalTrials.gov

Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 11, 2017

Primary Completion Date

January 10, 2022

Study Completion Date

February 3, 2022

Conditions
Vaginal Delivery
Interventions
DRUG

hyoscine butylbromide

Intravenous administration of hyoscine butylbromide during first stage of labor

DRUG

placebo

2ml of saline intravenous

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03055390 - Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women | Biotech Hunter | Biotech Hunter